The economic burden of pervasive developmental disorders in a privately insured population

Area of Science:

• Pediatric Health Economics
• Developmental Disorders Research
• Chronic Illness Management

Background:

• Healthcare cost and utilization patterns vary significantly among pediatric chronic conditions.
• Pervasive Developmental Disorders (PDDs) represent a complex group of neurodevelopmental conditions.
• Comparative economic analyses are crucial for understanding the financial burden of childhood diseases.

Purpose of the Study:

• To compare healthcare costs and utilization between children diagnosed with PDDs, asthma, or diabetes.
• To identify differences in healthcare resource use and expenditures for these pediatric conditions.

Main Methods:

• Analysis of claims data from a large U.S. commercial insurance plan.
• Comparison of total cost per child and outpatient claims pre- and post-diagnosis.
• Statistical control for age, gender, insurance plan, and prediagnosis costs.

Main Results:

• Children with PDDs exhibited significantly higher total costs and outpatient claims than those with asthma or diabetes, both pre- and post-diagnosis.
• Even after controlling for covariates, PDDs were associated with greater postdiagnosis healthcare costs.
• Privately insured children with PDDs demonstrated substantially higher healthcare utilization and outpatient service use.

Conclusions:

• Pediatric Pervasive Developmental Disorders are associated with significantly greater healthcare costs and utilization compared to asthma and diabetes.
• These findings highlight the substantial economic impact of PDDs on healthcare systems.
• Further research into cost-effective interventions and support for children with PDDs is warranted.